Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05669534 · ClinicalTrials.gov registry record · Phase 4
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
A Phase 4 study of HIV and Opioid Use Disorder, sponsored by University of Connecticut.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 256
- Enrollment target
- 1
- Study location
NCT05669534 is a Phase 4 study of HIV and Opioid Use Disorder that is actively recruiting participants, run by University of Connecticut. The registered enrollment target is 256 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05669534, a Phase 4 study of HIV and Opioid Use Disorder, is actively recruiting participants, sponsored by University of Connecticut.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the performance of four intervention components (Attention, Executive Functioning, Memory, and Information Processing) aimed at enhancing the ability of PWID on MOUD to process and utilize HIV prevention content, leading to improvements in HIV prevention information, motivation, behavioral skills, and behaviors (IMB).
Conditions Studied
Interventions
- BEHAVIORAL community-friendly health recovery program
- DRUG Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Study Locations (1)
Connecticut
- APT Foundation - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2027-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05669534
The ClinicalTrials.gov registry entry for NCT05669534 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (42% lower). The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which community-friendly health recovery program is the first listed.
NCT05669534 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT05669534 about?
NCT05669534 is a clinical study titled "Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP". The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the performance of four intervention components (Attention, Executive Functioning, Memory, and Information Processing) aimed at enha...
What is the current status of trial NCT05669534?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 256 participants. The study started on 2023-03-01. Estimated completion is 2027-01-01.
What conditions does trial NCT05669534 study?
This clinical trial studies the following conditions: HIV, Opioid Use Disorder.
What interventions are being tested in trial NCT05669534?
The interventions under investigation include: community-friendly health recovery program (BEHAVIORAL), Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis (DRUG).
Who is sponsoring clinical trial NCT05669534?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05669534 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
RECRUITING · Phase 4
-
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
RECRUITING · Phase 4
-
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
RECRUITING · Phase 4
-
Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
RECRUITING · Phase 4
-
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
ACTIVE NOT RECRUITING · Phase 4
-
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.